Featured Clinical Trials

The UNC Brain Metastasis Specialty Clinic seeks to offer a portfolio of clinical trials. Some of our most exciting trials are featured below.

ANG1005-04: A Phase II, Open-Label, Multi-Center Study of ANG1005 in Breast Cancer Patients with Recurrent Brain Metastases

PI: Carey Anders, MD

Study Coordinator:

Contact: 919-843-7047

DFCI10-107: Prospective Study of Neurocognitive Outcomes following Whole Brain Radiotherapy for Newly Diagnosed Brain Metastasis in Breast Cancer Patients

PI: Carey Anders, MD

Study Coordinator:

Contact: 929-966-4432

N107C: A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

PI: Tim Zagar, MD

Contact: 877-668-0683

LCCC1024: Phase I Dose-Escalation Study of BKM120 and Capecitabine in Patients with Metastatic Breast Cancer

PI: Claire Dees, MD

Study Coordinator:

Contact: 919-843-7047

DFCI11-477: Randomized Phase II Study of Fulvestrant with or without Ganetespib in Patients with Hormone Receptor-Positive, Metastatic Breast Cancer

PI: Carey Anders, MD

Study Coordinator:

Contact: 919-966-8577

A8641016: Study of Docetaxel and PF-03084014 in Metastatic or Locally Recurrent/Advanced Triple-Negative Breast Cancer

PI: Claire Dees, MD

Study Coordinator:

Contact: 919-843-7115

Search all UNC Lineberger Clinical Trials